| Kailyn Kyrine Cleveland, PHARMD | |
|
700 E Avalon, Kuna, ID 83634 | |
| (208) 789-4188 | |
| (208) 922-3568 |
| Full Name | Kailyn Kyrine Cleveland |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 700 E Avalon, Kuna, Idaho |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851900518 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | P8962 (Idaho) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kailyn Kyrine Cleveland, PHARMD 700 E Avalon, Kuna, ID 83634 Ph: (208) 789-4188 | Kailyn Kyrine Cleveland, PHARMD 700 E Avalon, Kuna, ID 83634 Ph: (208) 789-4188 |
News Archive
UT Southwestern Medical Center researchers have developed a classification for cancers caused by KRAS, the most frequently mutated gene in cancer, that could eventually help oncologists choose more effective, customized cancer therapies.
New research reveals that the greatest demand for liver transplantation due to hepatitis C (HCV)-related liver disease occurs among Americans born between 1941 and 1960. Findings in the December issue of Liver Transplantation, a journal published by Wiley on behalf of the American Association for the Study of Liver Diseases (AASLD), suggest that continuing increased demand for transplantation is driven by the development of liver cancer in baby boomers with HCV, but that the demand may decrease as patients born in this time period continue to grow older.
Elite Pharmaceuticals, Inc. announced today the signing of a license agreement and a manufacturing and supply agreement with Precision Dose, Inc. which has a wholly owned subsidiary, TAGI Pharma, Inc. which will distribute the products covered by the agreement. Pursuant to the License Agreement, TAGI Pharma will market and sell four Elite generic products in the United States, Puerto Rico and Canada.
Researchers at Purdue University have discovered a new approach for repairing damaged nerve fibers in spinal cord injuries using nano-spheres that could be injected into the blood shortly after an accident.
Boston Scientific Corporation today announced that its WallFlex Biliary RX Fully Covered Stent has received CE Mark approval for the treatment of benign biliary strictures.
› Verified 6 days ago
Travis Walthall, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 173 W 4th St, Kuna, ID 83634 Phone: 208-922-4400 Fax: 208-922-4499 | |
William Thompson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 700 E Avalon St, Kuna, ID 83634 Phone: 208-922-9836 | |
Chandler Rieske, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 700 E Avalon St, Kuna, ID 83634 Phone: 208-922-9836 | |
Shawn Barrow, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 869 E Avalon St, Kuna, ID 83634 Phone: 208-319-0205 | |
Katie Yvonne Gonzalez, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 869 E Avalon St, Kuna, ID 83634 Phone: 208-319-0205 Fax: 208-319-0211 | |
Denni Tiegs, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 700 E Avalon St, Kuna, ID 83634 Phone: 208-922-9834 | |
Dr. Eric Brandon Schlerf, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 173 W 4th St, Kuna, ID 83634 Phone: 208-922-4400 Fax: 208-922-4499 |